Arvinas (ARVN) News Today $8.13 -0.48 (-5.57%) Closing price 03/25/2025 04:00 PM EasternExtended Trading$8.27 +0.14 (+1.67%) As of 09:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), Eledon Pharmaceuticals (ELDN) and Arcutis Biotherapeutics (ARQT)March 25 at 3:46 AM | markets.businessinsider.comArvinas (NASDAQ:ARVN) Shares Down 5.1% - Here's WhyMarch 23 at 2:51 AM | americanbankingnews.comArvinas (NASDAQ:ARVN) Shares Down 5.1% - What's Next?Arvinas (NASDAQ:ARVN) Shares Down 5.1% - What's Next?March 22, 2025 | marketbeat.comFY2025 EPS Estimates for Arvinas Raised by Cantor FitzgeraldMarch 22, 2025 | americanbankingnews.comArvinas (NASDAQ:ARVN) Trading 4% Higher - Here's What HappenedArvinas (NASDAQ:ARVN) Shares Up 4% - Time to Buy?March 21, 2025 | marketbeat.comCantor Fitzgerald Increases Earnings Estimates for ArvinasArvinas, Inc. (NASDAQ:ARVN - Free Report) - Cantor Fitzgerald boosted their FY2025 earnings per share (EPS) estimates for Arvinas in a research report issued to clients and investors on Tuesday, March 18th. Cantor Fitzgerald analyst L. Watsek now expects that the company will post earnings per shMarch 21, 2025 | marketbeat.comInsider Selling: Arvinas, Inc. (NASDAQ:ARVN) Insider Sells 8,658 Shares of StockArvinas, Inc. (NASDAQ:ARVN - Get Free Report) insider Noah Berkowitz sold 8,658 shares of the company's stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $8.59, for a total transaction of $74,372.22. Following the completion of the sale, the insider now directly owns 110,023 shares in the company, valued at $945,097.57. This represents a 7.30 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.March 20, 2025 | marketbeat.comArvinas, Inc. (NASDAQ:ARVN) Insider Sells $74,372.22 in StockMarch 20, 2025 | insidertrades.comIs Arvinas, Inc. (ARVN) a Pump and Dump Stock Favored by Hedge Funds?March 18, 2025 | insidermonkey.comWedbush Issues Positive Outlook for Arvinas EarningsArvinas, Inc. (NASDAQ:ARVN - Free Report) - Investment analysts at Wedbush upped their Q1 2025 earnings per share (EPS) estimates for shares of Arvinas in a report issued on Wednesday, March 12th. Wedbush analyst R. Driscoll now expects that the company will post earnings of ($0.76) per share forMarch 18, 2025 | marketbeat.comResearch Analysts Issue Forecasts for Arvinas Q1 EarningsArvinas, Inc. (NASDAQ:ARVN - Free Report) - Wedbush boosted their Q1 2025 earnings per share estimates for Arvinas in a research note issued on Wednesday, March 12th. Wedbush analyst R. Driscoll now expects that the company will post earnings of ($0.76) per share for the quarter, up from their prMarch 17, 2025 | marketbeat.comArvinas (NASDAQ:ARVN) Given New $12.00 Price Target at Morgan StanleyMorgan Stanley reduced their price target on shares of Arvinas from $48.00 to $12.00 and set an "equal weight" rating on the stock in a research report on Thursday.March 14, 2025 | marketbeat.comGuggenheim Issues Pessimistic Forecast for Arvinas (NASDAQ:ARVN) Stock PriceGuggenheim cut their price objective on Arvinas from $57.00 to $32.00 and set a "buy" rating for the company in a research report on Thursday.March 14, 2025 | marketbeat.comArvinas (NASDAQ:ARVN) Downgraded to Neutral Rating by The Goldman Sachs GroupThe Goldman Sachs Group lowered Arvinas from a "buy" rating to a "neutral" rating and reduced their target price for the company from $70.00 to $15.00 in a report on Thursday.March 14, 2025 | marketbeat.comArvinas (ARVN) Moves 8.8% Higher: Will This Strength Last?March 13, 2025 | uk.finance.yahoo.comArvinas (NASDAQ:ARVN) Sees Strong Trading Volume - Here's What HappenedArvinas (NASDAQ:ARVN) Sees Strong Trading Volume - Should You Buy?March 13, 2025 | marketbeat.comWedbush Downgrades Arvinas (ARVN)March 13, 2025 | msn.comArvinas price target lowered to $12 from $48 at Morgan StanleyMarch 13, 2025 | markets.businessinsider.comArvinas price target lowered to $32 from $57 at GuggenheimMarch 13, 2025 | markets.businessinsider.comBank of America Has Lowered Expectations for Arvinas (NASDAQ:ARVN) Stock PriceBank of America dropped their price objective on Arvinas from $54.00 to $28.00 and set a "buy" rating for the company in a report on Wednesday.March 13, 2025 | marketbeat.comArvinas Holding Company (ARVN) Receives a Buy from GuggenheimMarch 13, 2025 | markets.businessinsider.comARVN Stock Plunges 53% Following Mixed Data From Breast Cancer StudyMarch 13, 2025 | finance.yahoo.comArvinas (NASDAQ:ARVN) Receives "Buy" Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $81.00 price target on shares of Arvinas in a report on Tuesday.March 12, 2025 | marketbeat.comOppenheimer Downgrades Arvinas (NASDAQ:ARVN) to Market PerformOppenheimer lowered Arvinas from an "outperform" rating to a "market perform" rating in a research report on Tuesday.March 12, 2025 | marketbeat.comArvinas (NASDAQ:ARVN) Hits New 12-Month Low - Here's WhyArvinas (NASDAQ:ARVN) Reaches New 12-Month Low - Should You Sell?March 12, 2025 | marketbeat.comArvinas Holding Company (ARVN) Receives a Buy from Truist FinancialMarch 12, 2025 | markets.businessinsider.comArvinas (NASDAQ:ARVN) Cut to "Neutral" at WedbushWedbush downgraded shares of Arvinas from an "outperform" rating to a "neutral" rating and lowered their target price for the company from $57.00 to $12.00 in a report on Wednesday.March 12, 2025 | marketbeat.comArvinas, Inc. (NASDAQ:ARVN) Given Consensus Rating of "Moderate Buy" by AnalystsArvinas, Inc. (NASDAQ:ARVN - Get Free Report) has been given an average rating of "Moderate Buy" by the thirteen brokerages that are covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The averMarch 12, 2025 | marketbeat.comArvinas downgraded to Perform from Outperform at OppenheimerMarch 11, 2025 | markets.businessinsider.comArvinas stock tumbles despite positive trial resultsMarch 11, 2025 | au.investing.comArvinas downgraded at Oppenheimer after trial misses co-primary endpointMarch 11, 2025 | markets.businessinsider.comArvinas price target lowered to $10 from $19 at CitiMarch 11, 2025 | markets.businessinsider.comArvinas, Pfizer Breast Cancer Drug Fails To Show Progression-Free Survival Benefit In TrialMarch 11, 2025 | benzinga.comArvinas-Pfizer's breast cancer treatment meets main goal in late-stage studyMarch 11, 2025 | reuters.comArvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical TrialMarch 11, 2025 | globenewswire.comCitigroup Issues Pessimistic Forecast for Arvinas (NASDAQ:ARVN) Stock PriceCitigroup reduced their target price on Arvinas from $28.00 to $19.00 and set a "neutral" rating on the stock in a research report on Friday.March 8, 2025 | marketbeat.comCandriam S.C.A. Sells 20,845 Shares of Arvinas, Inc. (NASDAQ:ARVN)Candriam S.C.A. lowered its stake in shares of Arvinas, Inc. (NASDAQ:ARVN - Free Report) by 4.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 503,936 shares of the company's stock after selling 20,845March 8, 2025 | marketbeat.comArvinas (NASDAQ:ARVN) Stock Price Up 4.8% - Here's What HappenedArvinas (NASDAQ:ARVN) Shares Up 4.8% - Still a Buy?March 7, 2025 | marketbeat.comArvinas price target lowered to $19 from $28 at CitiMarch 7, 2025 | markets.businessinsider.comStock Traders Buy High Volume of Arvinas Call Options (NASDAQ:ARVN)Arvinas, Inc. (NASDAQ:ARVN - Get Free Report) saw some unusual options trading on Wednesday. Traders acquired 5,428 call options on the stock. This is an increase of approximately 155% compared to the average volume of 2,130 call options.March 6, 2025 | marketbeat.comArvinas (NASDAQ:ARVN) Reaches New 52-Week Low - Time to Sell?Arvinas (NASDAQ:ARVN) Sets New 12-Month Low - Here's What HappenedMarch 5, 2025 | marketbeat.comArvinas to Participate in Upcoming Investor ConferencesMarch 4, 2025 | globenewswire.comInsider Selling: Arvinas, Inc. (NASDAQ:ARVN) CAO Sells 1,214 Shares of StockFebruary 26, 2025 | insidertrades.comArvinas, Inc. (NASDAQ:ARVN) CAO Sells $20,334.50 in StockArvinas, Inc. (NASDAQ:ARVN - Get Free Report) CAO David K. Loomis sold 1,214 shares of the stock in a transaction that occurred on Monday, February 24th. The shares were sold at an average price of $16.75, for a total value of $20,334.50. Following the transaction, the chief accounting officer now directly owns 18,863 shares of the company's stock, valued at $315,955.25. The trade was a 6.05 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.February 25, 2025 | marketbeat.comIan Taylor Sells 9,020 Shares of Arvinas, Inc. (NASDAQ:ARVN) StockArvinas, Inc. (NASDAQ:ARVN - Get Free Report) insider Ian Taylor sold 9,020 shares of the company's stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $16.71, for a total transaction of $150,724.20. Following the sale, the insider now directly owns 159,121 shares of the company's stock, valued at $2,658,911.91. This represents a 5.36 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.February 25, 2025 | marketbeat.comArvinas, Inc. (NASDAQ:ARVN) CEO Sells $523,971.36 in StockArvinas, Inc. (NASDAQ:ARVN - Get Free Report) CEO John G. Houston sold 31,338 shares of the stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $16.72, for a total value of $523,971.36. Following the completion of the sale, the chief executive officer now owns 1,157,480 shares of the company's stock, valued at approximately $19,353,065.60. This trade represents a 2.64 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.February 25, 2025 | marketbeat.comArvinas (NASDAQ:ARVN) Reaches New 12-Month Low - Time to Sell?Arvinas (NASDAQ:ARVN) Hits New 1-Year Low - Time to Sell?February 24, 2025 | marketbeat.comArvinas (ARVN) Expected to Announce Earnings on TuesdayArvinas (NASDAQ:ARVN) will be releasing earnings before the market opens on Tuesday, February 25, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=661679)February 23, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Koninklijke Philips (PHG), Arvinas Holding Company (ARVN) and Integer Holdings (ITGR)February 21, 2025 | markets.businessinsider.comArvinas (NASDAQ:ARVN) shareholders have endured a 72% loss from investing in the stock three years agoFebruary 21, 2025 | finance.yahoo.com Remove Ads Get Arvinas News Delivered to You Automatically Sign up to receive the latest news and ratings for ARVN and its competitors with MarketBeat's FREE daily newsletter. Email Address ARVN Media Mentions By Week ARVN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARVN News Sentiment▼0.840.79▲Average Medical News Sentiment ARVN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARVN Articles This Week▼136▲ARVN Articles Average Week Remove Ads Get Arvinas News Delivered to You Automatically Sign up to receive the latest news and ratings for ARVN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MIRM News Today EWTX News Today CNTA News Today KYMR News Today CGON News Today DNLI News Today ARWR News Today BLTE News Today ARQT News Today TARS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARVN) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arvinas, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arvinas With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARVN Stock Free ARVN Stock Alerts